1) topoisomerase Ⅱ(TOPⅡ)
TOPⅡ(拓扑异构酶)
2) topoisomerase
拓扑异构酶
1.
Identification of common species of dermatophytes by PCR-RFLP techniques targeting topoisomerase II gene;
拓扑异构酶II基因区PCR-RFLP法鉴别常见皮肤癣菌
2.
Investigation on the Raw Materials Plants Resources of Topoisomerase Inhibitor in Kunyu Mountain
昆嵛山拓扑异构酶抑制剂原料植物资源调查
3.
Objective To study the roles of DNA topoisomerases(Topo) in ovarian cancer TPT-resistant cells.
目的探讨DNA拓扑异构酶(Topoisomerase,Topo)在卵巢癌拓扑替康(TPT)耐药细胞A2780/TPT中的作用。
3) topoisomerase Ⅱ
拓扑异构酶
1.
Objective To detect the expression of p53、multidrug resistance gene1(mdr1) gene,glutathione S-transferase(GST-π),lung resistance protein(LRP),topoisomerase Ⅱ(Topo Ⅱ),and to evaluate their relationship with staging and classification of cancer,differentiation degree,lymphatic metastasis,and tumor invasion.
目的检测食管癌组织中P53、多药耐药基因(mu ltidrug resistance gene1,MDR1)及其编码产物P-糖蛋白(p-glycoprote in,P-gp)、肺耐药蛋白(lung resistance prote in,LRP)、谷胱甘肽S-转移酶(glutath ione S-transferase,GST-π)、拓扑异构酶(topoisom eraseⅡ,TopoⅡ)的表达水平,探讨其与临床分期、分化程度、淋巴结转移、肿瘤浸润深度及病理分型的关系。
4) topoiso-merase I
拓扑异构化酶
5) DNA topoisomerase
拓扑异构酶Ⅰ
1.
Camptothecin (CPT) compounds specifically acting on DNA topoisomerase Ⅰ (TopoI) are promising antitumor drugs, and have been widely used in the clinic.
喜树碱类抗肿瘤药物是DNA拓扑异构酶Ⅰ(1bpoisomerase I,TopoI)的特异性抑制剂,目前已广泛应用于临床。
2.
Camptothecin(CPT)compounds are specific inhibitors of DNA topoisomerase Ⅰ(TopoⅠ)which have been widely used in the clinic.
喜树碱类抗肿瘤药物是临床广泛使用的DNA拓扑异构酶Ⅰ (topoisomeraseⅠ ,TopoⅠ )的特异性抑制剂。
3.
Camptothecin(CPT)compounds are specific inhibitors o f DNA topoisomerase Ⅰ(TopoI)and have been widely used in the clinic.
喜树碱类抗肿瘤药物是临床广泛使用的经典的作用于DNA拓扑异构酶Ⅰ的特异性抑制剂。
6) DNA topoisomerases
DNA拓扑异构酶类
补充资料：top coating of leather
分子式：
CAS号：
性质：皮革的顶层涂饰。直接喷涂在中层上的涂饰层。顶层的薄膜应比中层硬，并与中层黏合良好。顶层薄膜的质量直接影响皮革外观及表观性能，要求光亮、滑爽，有抗水、抗有机溶剂及耐干、耐湿擦性能。
CAS号：
性质：皮革的顶层涂饰。直接喷涂在中层上的涂饰层。顶层的薄膜应比中层硬，并与中层黏合良好。顶层薄膜的质量直接影响皮革外观及表观性能，要求光亮、滑爽，有抗水、抗有机溶剂及耐干、耐湿擦性能。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条